Skip to main content
. 2003 Jan 24;100(3):1169–1173. doi: 10.1073/pnas.0437889100

Figure 6.

Figure 6

Ref-1 inhibitor PNRI-299 reduces allergy airway inflammation. (a) OVA-treated mice have a dense inflammatory cell infiltrate (arrows) surrounding the airways (AW) and blood vessels (BV) and mucus hypersecretion not seen in saline controls (c). (b) PNRI-299 (0.75 mg/kg) reduced the airway inflammatory cell infiltration (arrows) and mucus release in OVA-treated mice.